Cargando…
Laparoscopic Sleeve Gastrectomy and Crural Repair as a Treatment of Morbid Obesity Associated with Gastroesophageal Reflux
OBJECTIVE: The aim of this study was to evaluate the Laparoscopic Sleeve Gastrectomy (LSG) with simultaneous crural repair in treatment of morbid obesity associated with gastroesophageal reflux disease. METHODS: This prospective observational study was carried out from September 2012 to July 2016 in...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Electronic physician
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308491/ https://www.ncbi.nlm.nih.gov/pubmed/28243403 http://dx.doi.org/10.19082/3529 |
_version_ | 1782507538376294400 |
---|---|
author | Attia, Sameh Gabr |
author_facet | Attia, Sameh Gabr |
author_sort | Attia, Sameh Gabr |
collection | PubMed |
description | OBJECTIVE: The aim of this study was to evaluate the Laparoscopic Sleeve Gastrectomy (LSG) with simultaneous crural repair in treatment of morbid obesity associated with gastroesophageal reflux disease. METHODS: This prospective observational study was carried out from September 2012 to July 2016 in Al-Azhar University Hospital (Egypt). The study was conducted on 53 patients, 14 males (26.4%) and 39 females (73.6%) with the mean age 36.2 years (range 18–52 years), presenting with morbid obesity and reflux disease either symptomatic patients or asymptomatic (Endoscopic & Manometric), their mean Body Mass Index (BMI) was 50.1 kg/m(2) (range 40–62 kg/m(2)), who underwent LSG and antireflux procedure (crural repair). RESULTS: Excess weight Loss (EWL); the mean EWL at 6 months postoperatively was 46.3%, at 12 months was 54%, and at 18 months was 61%. Also, we found that, preoperative co-morbidities are resolved by 53% and improved by 23%. Reflux symptoms were absent in 30 patients (56 %), improved in 14 patients (26.4 %), but persistent in 7 patients (13.2 %). CONCLUSION: Laparoscopic crural closure, during LSG, represents a valuable option for the treatment of morbid obesity and gastroesophageal reflux, and can result in favorable outcomes in terms of weight loss and gastroesophageal reflux disease (GERD) symptoms control. |
format | Online Article Text |
id | pubmed-5308491 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Electronic physician |
record_format | MEDLINE/PubMed |
spelling | pubmed-53084912017-02-27 Laparoscopic Sleeve Gastrectomy and Crural Repair as a Treatment of Morbid Obesity Associated with Gastroesophageal Reflux Attia, Sameh Gabr Electron Physician Original Article OBJECTIVE: The aim of this study was to evaluate the Laparoscopic Sleeve Gastrectomy (LSG) with simultaneous crural repair in treatment of morbid obesity associated with gastroesophageal reflux disease. METHODS: This prospective observational study was carried out from September 2012 to July 2016 in Al-Azhar University Hospital (Egypt). The study was conducted on 53 patients, 14 males (26.4%) and 39 females (73.6%) with the mean age 36.2 years (range 18–52 years), presenting with morbid obesity and reflux disease either symptomatic patients or asymptomatic (Endoscopic & Manometric), their mean Body Mass Index (BMI) was 50.1 kg/m(2) (range 40–62 kg/m(2)), who underwent LSG and antireflux procedure (crural repair). RESULTS: Excess weight Loss (EWL); the mean EWL at 6 months postoperatively was 46.3%, at 12 months was 54%, and at 18 months was 61%. Also, we found that, preoperative co-morbidities are resolved by 53% and improved by 23%. Reflux symptoms were absent in 30 patients (56 %), improved in 14 patients (26.4 %), but persistent in 7 patients (13.2 %). CONCLUSION: Laparoscopic crural closure, during LSG, represents a valuable option for the treatment of morbid obesity and gastroesophageal reflux, and can result in favorable outcomes in terms of weight loss and gastroesophageal reflux disease (GERD) symptoms control. Electronic physician 2017-01-25 /pmc/articles/PMC5308491/ /pubmed/28243403 http://dx.doi.org/10.19082/3529 Text en © 2017 The Authors This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/3.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Original Article Attia, Sameh Gabr Laparoscopic Sleeve Gastrectomy and Crural Repair as a Treatment of Morbid Obesity Associated with Gastroesophageal Reflux |
title | Laparoscopic Sleeve Gastrectomy and Crural Repair as a Treatment of Morbid Obesity Associated with Gastroesophageal Reflux |
title_full | Laparoscopic Sleeve Gastrectomy and Crural Repair as a Treatment of Morbid Obesity Associated with Gastroesophageal Reflux |
title_fullStr | Laparoscopic Sleeve Gastrectomy and Crural Repair as a Treatment of Morbid Obesity Associated with Gastroesophageal Reflux |
title_full_unstemmed | Laparoscopic Sleeve Gastrectomy and Crural Repair as a Treatment of Morbid Obesity Associated with Gastroesophageal Reflux |
title_short | Laparoscopic Sleeve Gastrectomy and Crural Repair as a Treatment of Morbid Obesity Associated with Gastroesophageal Reflux |
title_sort | laparoscopic sleeve gastrectomy and crural repair as a treatment of morbid obesity associated with gastroesophageal reflux |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308491/ https://www.ncbi.nlm.nih.gov/pubmed/28243403 http://dx.doi.org/10.19082/3529 |
work_keys_str_mv | AT attiasamehgabr laparoscopicsleevegastrectomyandcruralrepairasatreatmentofmorbidobesityassociatedwithgastroesophagealreflux |